Navigation Links
APS Healthcare and Thomson Reuters to Manage New York State's Medicaid Clinical Best Practices Review Program

Health Analytics and Utilization Review Services to Improve Safety and Quality of Care

WHITE PLAINS, N.Y., April 16 /PRNewswire/ -- APS Healthcare, a leading provider of specialty healthcare solutions, and Thomson Reuters, a global business information company, have been selected by the New York State Department of Health to manage the state's Medicaid clinical best practice utilization review program. The program examines how Medicaid patients utilize medical services and explores patterns of potentially unnecessary care and opportunities for improving patient safety or quality of care. The results of sophisticated analytics will be provided to physicians and clinics to enhance the opportunity to improve clinical outcomes through increased knowledge of patients' adherence to treatment or, in some cases, patients overuse of treatment services.

(Logo: )

The project leverages the clinical and behavior change expertise of APS Healthcare and the unique analytic and predictive modeling capabilities of the Medstat Advantage Suite(R) application from Thomson Reuters to identify patient safety issues and flag healthcare services that are duplicative or outside evidenced-based practice guidelines. It will give New York State practitioners prioritized, actionable information they can use to improve health outcomes for Medicaid members.

"This program will help us ensure that services delivered to Medicaid members are medically appropriate, effective and efficient," said James Figge, MD, medical director, Office of Health Insurance Programs (OHIP).

Under the contract, APS will be responsible for reviewing fee-for-service Medicaid claims to identify practice patterns that may not conform to physician-developed evidence-based standards, provide information about documented best practices that improve outcomes (e.g., dilated eye exams for diabetic patients), and involve clinician peers who will collaborate with the provider community before, during and after implementation of this initiative.

"Collaboration is critical and can be optimized through regular communication and education of physicians through clinical peers. We support this initiative because it will enhance the quality of care delivered to NY Medicaid recipients," said Michael H. Rosenberg, MD, president, Medical Society of the State of New York.

"Combining APS' clinical and analytical expertise with Thomson Reuters's advanced business intelligence and clinical support tool will improve the quality of care that New York Medicaid members receive," said Jerry Vaccaro, MD, president and chief operating officer of APS Healthcare. "Through this data-driven and evidence-based approach, we can also help the state make better use of their healthcare resources and lessen the burden of Medicaid spending on the state budget."

APS, which operates 41 Medicaid programs in 26 states and Puerto Rico, focuses on improving overall health and wellness through education and interventions that promote behavior change, improve health outcomes and reduce long-term healthcare costs. Thomson Reuters' Advantage Suite(R) is currently used for data analytics and decision support by Medicaid and other government agencies in 28 states.

Thomson Reuters will deploy its Medstat Advantage Suite(R) solution, which combines a customized repository of healthcare data with a comprehensive set of analytic tools. The system generates intelligence and benchmarks that governmental agencies use to analyze and manage the cost and quality of healthcare delivered to their beneficiaries.

"We're proud to partner with APS Healthcare to serve the State of New York, using Advantage Suite's advanced methodologies and business intelligence applications to power APS' innovative and data-driven interventions," said Jon Newpol, executive vice president of the Thomson Reuters Healthcare and Science business. "We are confident our services will benefit the state, its healthcare practitioners and ultimately, its Medicaid members."

The project, scheduled to start by early Summer 2009, will review the healthcare services delivered to three million New York fee-for-service Medicaid recipients.

About APS Healthcare

APS Healthcare, headquartered in White Plains, NY, is a leading provider of specialty healthcare solutions. The company partners with state agencies in 24 states and Puerto Rico, which serve more than 40 percent of the nation's Medicaid population. APS delivers customized, integrated healthcare solutions that help people engage in behaviors that optimize their health status. By uniting all participants in the healthcare landscape -- individuals, practitioners and payers -- APS improves overall health and reduces total healthcare expenditures. For more information, visit

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, visit


    Kara Dornig
    (914) 288-4772

    David Wilkins
    (734) 913-3397

SOURCE APS Healthcare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
5. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
6. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
10. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):